Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
Contact us with questions
Mounjaro - European Public Assessment Report
We also used a self-controlled case series design [19], which comprised of new users of GLP-1 RAs ( n = 85,717 ) or SGLT-2 inhibitors ( n = 78,366 ) or DPP-4 inhibitors ( n = 35,762) from 2014 to 2022
16-18 Nausea is the most frequently reported AE among GLP-1 RAs, with rates ranging from 20% to 40% depending on the agent and dose
That's a genuine cost
US$ 23.37
US$ 24.54
US$ 28.73
US$ 27.35
US$ 27.24
